Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Commercial
Commercial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low Cardiovascular Event Rates in Elderly NVAF Patients on LIXIANA (edoxaban)
Firstwordpharma News
-
October 13, 2019
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Commercial
BioSpace Movers & Shakers, Oct. 11
Commercial
ChromaDex Statement Regarding the October 9th Order in the Central District...
Biospace News
-
October 11, 2019
0
Commercial
Ginkgo Bioworks Explodes with Fundraising and Partnerships
Biospace News
-
October 11, 2019
0
Commercial
Harbour BioMed Announces Completion of Phase 2 Study in China of...
Biospace News
-
October 11, 2019
0
Commercial
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator...
Biospace News
-
October 11, 2019
0
Deals
Incyte to Report Third Quarter 2019 Financial Results
Biospace News
-
October 10, 2019
0
1
2
3
...
272
Page 1 of 272
- Advertisement -
MOST POPULAR
ViiV Healthcare’s 2-Drug Combo for HIV Approved by FDA
April 9, 2019
Shares of BioCryst Fall After Phase III HAE Drug Underwhelms Investors
May 21, 2019
TerrAscend to Present at 2019 GMP Securities Cannabis Conference
April 12, 2019
Verastem Oncology to Announce Fourth Quarter and Full-Year 2018 Financial Results...
February 26, 2019
Load more
HOT NEWS
Deals
Gore Range Announces Strategic Partnership Investment from LEO Pharma
Psychiatry
Physician Views snap-poll: Psychiatrists answer five key questions about Sage Therapeutics’...
Neurology
Marathon-running molecule could speed up the race for new neurological treatments
Others
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical...
